CYP2D6 intermediate metabolizer status could slow down Plasmodium falciparum gametocyte clearance after single-dose primaquine

Eitemau Tebyg

• CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum
  gan: Pett, Helmi, et al.
  Cyhoeddwyd: (2019)
• Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children
  gan: Gonçalves, Bronner P., et al.
  Cyhoeddwyd: (2017)
• Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda
  gan: Eziefula, Alice Chijioke, et al.
  Cyhoeddwyd: (2013)
• Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
  gan: Gonçalves, Bronner P., et al.
  Cyhoeddwyd: (2016)
• A Molecular Assay to Quantify Male and Female Plasmodium falciparum Gametocytes: Results From 2 Randomized Controlled Trials Using Primaquine for Gametocyte Clearance
  gan: Stone, Will, et al.
  Cyhoeddwyd: (2017)